# CellonTech breaks ground on biocolagen medical device plant in Namyangju, South Korea

CellonTech, a subsidiary of SC Engineering, broke ground on a new advanced manufacturing facility for biocolagen medical devices in Namyangju, South Korea. The plant will have a total floor area of 16,531 m² and is expected to start production by end of 2026, with a total investment of 55 billion KRW.

- Type: New facility
- Announced: 2025-08-26
- Where: Namyangju, Gyeonggi Province, South Korea, South Korea
- Value: $41.0M (55.0B KRW)
- Starts operating: 2026
- Status: under construction
- Capacity: 5 times current production capacity
- Products: biocolagen medical devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [CellonTech](https://endata.com/companies/78594.md)
- [SC Engineering](https://endata.com/companies/2437.md) (investor)

## Sources

- [news.nate.com](https://news.nate.com/view/20250826n24178), 2025-08-26: "금곡공장 착공은 이미 포화상태에 이른 기존 생산시설의 한계를 넘어서는 동시에 글로벌 수요와 규제에 대응할 수 있는 첨단 제조역량을 확보함으로써 중대한 성장 전환점을 마련한다는 데 큰 의미가 있다."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.